Thursday, May 23, 2013 10:03:21 AM
From Jason's AMBS Zack's Report, 5/22/13, pg. 13
Also, from pg.12
"MANF will be delivered to the affected areas of the brain through a next-generation implanted catheter system designed to deliver drugs at the right pressure to overcome previous failed efforts with GDNF and other neurotrophic factors. In this regard, we expect that Amarantus will strike a partnership with a firm specializing in CED ("convection enhanced delivery platform") later in 2013, with the two major players being UK-based Renishaw and German-based BrainLab."
Credit due-Gatortail found this little tidbit yesterday.
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM